161 related articles for article (PubMed ID: 29115557)
1. Hypoxia induces differential expression patterns of osteopontin and CD44 in colorectal carcinoma.
Wohlleben G; Hauff K; Gasser M; Waaga-Gasser AM; Grimmig T; Flentje M; Polat B
Oncol Rep; 2018 Jan; 39(1):442-448. PubMed ID: 29115557
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer.
Rao G; Wang H; Li B; Huang L; Xue D; Wang X; Jin H; Wang J; Zhu Y; Lu Y; Du L; Chen Q
Clin Cancer Res; 2013 Feb; 19(4):785-97. PubMed ID: 23251004
[TBL] [Abstract][Full Text] [Related]
3. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.
Shirasaki T; Honda M; Yamashita T; Nio K; Shimakami T; Shimizu R; Nakasyo S; Murai K; Shirasaki N; Okada H; Sakai Y; Sato T; Suzuki T; Yoshioka K; Kaneko S
Sci Rep; 2018 Sep; 8(1):13143. PubMed ID: 30177680
[TBL] [Abstract][Full Text] [Related]
4. CD44v6 engages in colorectal cancer progression.
Ma L; Dong L; Chang P
Cell Death Dis; 2019 Jan; 10(1):30. PubMed ID: 30631039
[TBL] [Abstract][Full Text] [Related]
5. The CD44 standard isoform contributes to radioresistance of pancreatic cancer cells.
Tsubouchi K; Minami K; Hayashi N; Yokoyama Y; Mori S; Yamamoto H; Koizumi M
J Radiat Res; 2017 Nov; 58(6):816-826. PubMed ID: 29106581
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin-4 and Osteopontin-5 splice variants are expressed in several tumor cell lines.
Silva GR; Mattos DS; Bastos ACF; Viana BPPB; Brum MCM; Ferreira LB; Gimba ERP
Mol Biol Rep; 2020 Oct; 47(10):8339-8345. PubMed ID: 33006711
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells.
Gao C; Guo H; Downey L; Marroquin C; Wei J; Kuo PC
Carcinogenesis; 2003 Dec; 24(12):1871-8. PubMed ID: 12949055
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of osteopontin and CD44 correlates with infertility status in PCOS patients.
Paravati R; De Mello N; Onyido EK; Francis LW; Brüsehafer K; Younas K; Spencer-Harty S; Conlan RS; Gonzalez D; Margarit L
J Mol Med (Berl); 2020 Dec; 98(12):1713-1725. PubMed ID: 33047155
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
[TBL] [Abstract][Full Text] [Related]
10. CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway.
Jijiwa M; Demir H; Gupta S; Leung C; Joshi K; Orozco N; Huang T; Yildiz VO; Shibahara I; de Jesus JA; Yong WH; Mischel PS; Fernandez S; Kornblum HI; Nakano I
PLoS One; 2011; 6(9):e24217. PubMed ID: 21915300
[TBL] [Abstract][Full Text] [Related]
11. Control of the human osteopontin promoter by ERRα in colorectal cancer.
Boudjadi S; Bernatchez G; Beaulieu JF; Carrier JC
Am J Pathol; 2013 Jul; 183(1):266-76. PubMed ID: 23680656
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.
Bánky B; Rásó-Barnett L; Barbai T; Tímár J; Becságh P; Rásó E
Mol Cancer; 2012 Nov; 11():83. PubMed ID: 23151220
[TBL] [Abstract][Full Text] [Related]
13. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation.
Khan SA; Cook AC; Kappil M; Günthert U; Chambers AF; Tuck AB; Denhardt DT
Clin Exp Metastasis; 2005; 22(8):663-73. PubMed ID: 16691370
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.
Huang J; Pan C; Hu H; Zheng S; Ding L
PLoS One; 2012; 7(10):e47901. PubMed ID: 23112867
[TBL] [Abstract][Full Text] [Related]
15. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
16. Influence of hypoxia and irradiation on osteopontin expression in head and neck cancer and glioblastoma cell lines.
Wohlleben G; Scherzad A; Güttler A; Vordermark D; Kuger S; Flentje M; Polat B
Radiat Oncol; 2015 Aug; 10():167. PubMed ID: 26259597
[TBL] [Abstract][Full Text] [Related]
17. Silencing of osteopontin promotes the radiosensitivity of breast cancer cells by reducing the expression of hypoxia inducible factor 1 and vascular endothelial growth factor.
Yang L; Zhao W; Zuo WS; Wei L; Song XR; Wang XW; Zheng G; Zheng MZ
Chin Med J (Engl); 2012 Jan; 125(2):293-9. PubMed ID: 22340562
[TBL] [Abstract][Full Text] [Related]
18. Influence of osteopontin expression on the metastatic growth of CC531 rat colorectal carcinoma cells in rat liver.
Uhlmann ME; Georges RB; Boleij A; Eyol E; Kubarenko A; Adwan H; Berger MR
Cancer Gene Ther; 2011 Nov; 18(11):795-805. PubMed ID: 21852811
[TBL] [Abstract][Full Text] [Related]
19. Common Variants in Osteopontin and
Gałecki S; Gdowicz-Kłosok A; Deja R; Masłyk B; Giglok M; Suwiński R; Butkiewicz D
Cells; 2023 Nov; 12(23):. PubMed ID: 38067149
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
